Open Lending Corporation (LPRO)
USD 6.2
(-5.49%)
USD 6.2
(-5.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 82.65 Million | 107.43 Million | 95.15 Million | 24.64 Million | 41.76 Million | 28.6 Million |
| Net Income | 22.07 Million | 66.62 Million | 146.08 Million | -97.56 Million | 62.54 Million | 28.27 Million |
| Depreciation & Amortization | 1.15 Million | 1.33 Million | 1.12 Million | 1.76 Million | 105 Thousand | 80 Thousand |
| Deferred income taxes | -4.98 Million | 375 Thousand | 20.05 Million | 4.73 Million | - | - |
| Stock-based compensation | 9.49 Million | 5.44 Million | 3.81 Million | 2.82 Million | 1.98 Million | 2.52 Million |
| Change in working capital | 53.85 Million | 33.06 Million | -29.81 Million | -19.05 Million | -22.96 Million | -2.31 Million |
| Other non-cash items | 1.06 Million | 579 Thousand | -46.1 Million | 131.93 Million | 92 Thousand | 30 Thousand |
| Investing Cash Flow | -2.17 Million | -624 Thousand | -1.98 Million | -1.19 Million | -99 Thousand | -106 Thousand |
| Investments in PPE | -2.17 Million | -624 Thousand | -1.98 Million | -1.19 Million | -99 Thousand | -106 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -275 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.05 Million | -386 Thousand | -1.87 Million | - | - | 760.2 Thousand |
| Financing Cash Flow | -42.33 Million | -17.79 Million | -77.8 Million | 70.8 Million | -44.9 Million | -21.37 Million |
| Debt repayment | -3.75 Million | -148.59 Million | -194.19 Million | -6.52 Million | -2.5 Million | -2.5 Million |
| Dividends payments | - | - | - | -135.59 Million | -42.4 Million | -18.87 Million |
| Common Stock Repurchased | -37.32 Million | -18.01 Million | -20 Million | -37.5 Million | - | - |
| Common Stock Issuance | - | - | - | 275.34 Million | - | 276.69 Million |
| Other Financing Activities | -1.25 Million | 148.81 Million | 136.38 Million | -24.92 Million | -2.5 Million | - |
| Accounts receivables | 47.22 Million | 804 Thousand | -2.18 Million | -585 Thousand | -1.82 Million | -443 Thousand |
| Accounts payables | 86 Thousand | -996 Thousand | -2.15 Million | 2.1 Million | 583 Thousand | 378 Thousand |
| Inventory | - | - | -25.03 Million | -20.03 Million | - | 360 Thousand |
| Other working capital | 6.55 Million | 33.26 Million | -450 Thousand | -548 Thousand | -21.71 Million | -2.61 Million |
| Cash at beginning of period | 208.51 Million | 119.5 Million | 104.14 Million | 9.89 Million | 13.13 Million | 6.01 Million |
| Cash at end of period | 246.66 Million | 208.51 Million | 119.5 Million | 104.14 Million | 9.89 Million | 13.13 Million |
| Capital Expenditure | -2.17 Million | -624 Thousand | -1.98 Million | -1.19 Million | -99 Thousand | -106 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 38.15 Million | 89.01 Million | 15.36 Million | 94.25 Million | -3.23 Million | 7.11 Million |
| Free Cash Flow | 80.48 Million | 106.8 Million | 93.16 Million | 23.44 Million | 41.66 Million | 28.49 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.9 Million | 5.08 Million | 22.07 Million | -4.84 Million | 3 Million | 11.37 Million |
| Depreciation & Amortization | 415 Thousand | 372 Thousand | 1.15 Million | 335 Thousand | 328 Thousand | 252 Thousand |
| Deferred income taxes | 1.7 Million | 2.15 Million | -4.98 Million | -5.37 Million | -1.39 Million | 561 Thousand |
| Stock-based compensation | 2.36 Million | 1.85 Million | 9.49 Million | 2.66 Million | 2.66 Million | 2.31 Million |
| Change in working capital | -9.06 Million | 1.22 Million | 53.85 Million | 23.69 Million | 15.45 Million | 1.29 Million |
| Other non-cash items | 3.49 Million | 310 Thousand | 1.06 Million | 272.99 Thousand | 269 Thousand | 269 Thousand |
| Investing Cash Flow | -1.08 Million | -642 Thousand | -2.17 Million | -590 Thousand | -745 Thousand | -508 Thousand |
| Investments in PPE | -1.08 Million | -642 Thousand | -2.17 Million | -590 Thousand | -745 Thousand | -508 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.03 Million | -642 Thousand | -2.05 Million | -570 Thousand | -719 Thousand | -467 Thousand |
| Financing Cash Flow | -116 Thousand | -1.95 Million | -42.33 Million | -7.9 Million | -10.95 Million | -1.08 Million |
| Debt repayment | - | -938 Thousand | -3.75 Million | -937 Thousand | -938 Thousand | -937 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -116 Thousand | -1.02 Million | -37.32 Million | -6 Million | -9.99 Million | -146 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -116 Thousand | -1.02 Million | -1.25 Million | -970 Thousand | -13 Thousand | -146 Thousand |
| Accounts receivables | -491 Thousand | -1.13 Million | 47.22 Million | 20.56 Million | 1.06 Million | 291 Thousand |
| Accounts payables | 458 Thousand | 66 Thousand | 86 Thousand | 153 Thousand | 192 Thousand | -713 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -9.03 Million | 4.91 Million | 6.55 Million | 2.97 Million | 14.2 Million | 1.72 Million |
| Cash at beginning of period | 255.07 Million | 246.66 Million | 208.51 Million | 238.41 Million | 229.78 Million | 215.3 Million |
| Cash at end of period | 252.46 Million | 255.07 Million | 246.66 Million | 246.66 Million | 238.41 Million | 229.78 Million |
| Capital Expenditure | -1.08 Million | -642 Thousand | -2.17 Million | -590 Thousand | -745 Thousand | -508 Thousand |
| Effect of forex changes on cash | - | - | - | 1.00 | - | -538 Thousand |
| Net cash flow / Change in cash | -2.61 Million | 8.4 Million | 38.15 Million | 8.25 Million | 8.62 Million | 14.48 Million |
| Free Cash Flow | -2.49 Million | 10.36 Million | 80.48 Million | 16.16 Million | 19.57 Million | 15.56 Million |
IGCIL
9009
601828
WEGE3
HCMLF
ZYME